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Many methods for plasmid purification have been developed, and the whole process must be designed 
to remove the host RNA, protein, genomic DNA and endotoxin. Currently, plasmid is mostly purified by 
time-consuming chromatographies. As an alternative, a new plasmid purification technology with 
cetyltrimethylammonium bromide (CTAB) is described. After lysis with alkali, the CTAB was directly 
titrated into the supernatant for plasmid precipitation, then the coprecipitated pellets were dealt with 3 
M KAc and TritonX-114. Quality detection showed that the purified plasmids were free from the 
contamination of host RNA. In 1 mg purified plasmid, the bacterial genomic DNA, host endotoxin and 
protein were less than 10 g/ mg, 50 EU/ mg and 10 g/mg, respectively. The ratio of OD260/OD280 was 
between 1.75 - 1.85, more than 90% of the prepared plasmid presented in the supercoiled form. Further 
test demonstrated that the pcDNAlacZ purified with CTAB and authoritative endotoxin-free plasmid Kit 
had the similar transfection efficiency in vivo and in vitro. CTAB can be used for plasmid purification; 
the main advantages of the DNAs purified with CTAB include the avoidance of animal-derived enzymes, 
toxic substance like chloroform and phenol. More attractive is that the whole process has the 
predominance of low cost. 
 





In recent years, gene therapy and gene vaccination have 
developed quickly as new ways for disease prevention 
and treatment. Large-scale processes to manufacture 
plasmid DNA of high quality are needed for animal 
experiments, clinical test and sequential application. 
Plasmids should be produced reproducibly to meet the 
stringent quality criteria in terms of purity, safety and 
efficacy. Taking into account the application of animal 
DNA vaccine, the cost of purification must be decreased. 
Although commonly used in laboratory-scale methods for 
the isolation of plasmid DNA, organic reagents, 
mutagenic and toxic compounds (phenol) and animal 
derived enzymes (lysozyme, proteinase K, and RNase A) 
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and must be avoided (Prazeres et al., 1999). Another 
challenge in the purification of plasmid is the elimination 
of cellular components from the host (Escherichia coli) 
that potentially induce immunological and biological 
responses. Final plasmid (p) preparations should be free 
from genomic (g) DNA (<0.05 g gDNA/g pDNA), host 
proteins (undetectable by bicinchoninicacid assay or 
silver-staining gel), RNA (not seen in 0.8% agarose gel) 
and endotoxins (<0.1 EU/g pDNA) (Gustavsson et al., 
2004). The presence of host impurities and manufac-
turing related compounds in the final preparations may 
lead to dose-related toxicity effects during in vivo 
transfection studies. 
Chromatographic techniques, such as size-exclusion 
chromatography (Li et al., 2007), anion exchange 
(Prazeres et al.,1998; Eon-Duval et al., 2004) and hydro-
phobic interaction chromatography (Diogo et al., 2000) 
have been mostly used at large scale to obtain final pure 





phy and aqueous two-phase extraction system have also 
been described, but for lab-scale applications (Balan et 
al., 2003; Darby and Hine, 2005; Trindade et al., 2003). 
Other non-chromatographic techniques, such as tangen-
tial flow filtration, superparamagnetic nanoparticles and 
zwitterionic detergent have been also reported (Eon-
Duval et al., 2003; Chiang et al., 2005; Chowdhury and 
Toshihiro, 2005). 
Considering the current techniques for plasmid purifi-
cation suffer from the complicated processes, and the 
cost is too high for animal application. So, it is necessary 
to establish a suitable large-scale purification technology. 
In the present study, we selected the CTAB as the 
reagent to precipitate the supercoiled DNA from the 
supernatant after alkali lysis, while RNA and most host 
protein and endotoxin still hold in the supernatant. 
Followed by the precipitation, the plasmids are released 
form the pellet complex by 3 M KAc, and the endotoxin is 
removed with TritonX-114 finally. 
 
 




Unless stated otherwise, all reagents and chemicals were obtained 
from commercial sources. CTAB (Amresco) was used to precipitate 
plasmid selectively, EndoFree Plasmid Mega Kit (QIAGEN) for 
control plasmid, TritonX-114 for endotoxin removal (Sigma) and gel 
clot tachypleus amebocyte lysate (chinese, Xia men) for endotoxin 
quantification, BCA protein assay kit (Pierce) for bacterial protein 
detection, DIG DNA Labeling and Detection Kit (Roche) and -
Galactosidase Enzyme Assay System With Reporter Lysis Buffer 




Bacterial strains, cells, plasmids and animals 
 
Except pMDT-18 (Takara), plasmid pcDNAlacZ containing -
galactosidase gene, pCpG1, pCPG2, pCpG3 and pCpG4 with 
different copies CpG oligonucleotide motifs; pETAII and pETIB with 
gene of Actinobacillus pleuropneumoniae protective antigen, 
eukaryotic expression vector pcDNK with antikanamycin gene all 
were constructed and preserved in our laboratory.  
 
 
Alkali lysis of recombinant Escherichia coli 
 
Followed by fermentation, the recombinant E. coli bacteria were 
centrifugated at 6000 g, 10 min for collection. The pellets was 
suspended with solution I [25 mM Tris-HCl (H8.0), 10 mM EDTA, 50 
mM Glucose], then the solution II (200 mM NaOH, 1% SDS) and 
solution III (3 M KAc, 5 M CH3COOH) were added as described 
elsewhere (Sambrook et al., 1989). Fifty minutes later, the residue 
was removed by centrifugation at 6000 g for 10 min and the 
supernatant was collected. 
 
 
Selective precipitation of plasmid DNA 
 
In order to precipitate plasmid, 5% (w/v) CTAB was titrated into the 
supernatant with agitation at 15 r/min at room temperature to final 
concentration from 0 to 25% (v/v), in which consecutive mixture 
were sampled. The samples were analyzed by agarose gel  electro- 




phoresis, BCA and spectrum. Then the plasmids with different 
concentrations and molecular weight were precipitated with the 
assumptive concentration of CTAB. 
 
 
Selective release of plasmid DNA 
 
Pellets of plasmid DNA coprecipitated with CTAB were divided into 
ten equal parts, and the ten aliquots were dissolved by 10 mM TE 
(pH 8.0), PBS (pH 7.2), DDW, 3 M NaCl, 5 M NaCl, 1 M NaAc, 3 M 
NaAc, 0.5 M NH4Ac, 1 M Na3PO4 and 3 M KAc, respectively. After 
centrifugation at 15°C, 6000 g for 10 min, the supernatants were 
collected for OD260 and OD280 analysis, and the plasmid DNA 
recoveries of released plasmid DNA in the solutions were 
calculated according to the formula (Recovery = plasmid in 





The plasmid DNA purification was concentrated and dissolved in 10 
mM TE buffer and then 10% TritonX-114 was added to a final 
concentration of 1, 2 and 3%. After ice incubation for 10 min, the 
mixture was immediately transfered to 20, 26, 32 and 42°C water 
bath for another 10 min, afterwards centrifugation was carried out at 
10000 g for 5 min at 20°C. And the plasmid presented in the 
supernatant was collected. The operation procedure may be 
repeated when needed. 
 
 
Plasmid identification with restriction digestion 
 
The purified plasmid pcDNAlacZ was digested with HindIII and 
BamHI, HindIII and EcoRI, HindIII and XhoI, respectively at 37°C 






Gel electrophoresis was performed on 0.7% agarose gels in TBE 
Buffer (0.089 M Tris–borate, pH 8.0, 2 mM EDTA), 15 µL of sample 
(including 2.5 L of a 50% solution of glycerol in water was loaded 
in each well and the samples were run at 60 V for 60 min. When the 
electrophoresis was completed, the agarose gel was stained with 
ethidium bromide by soaking the gel in 100 mL TBE buffer 
containing 1.5 g ethidium bromide for 30 min. The agarose gel was 
analyzed and photographed using the gel documentation software 
418 (Tanon, Shang hai, China). 
 
 
Host protein detection  
 
Protein concentration was measured by the bicinchoninic acid 
assay. Final protein concentrations in the purified plasmid fractions 
were determined by the BCA assay. One mL samples were added 
to 1 mL BCA reagent and incubated for 60 min at 60°C. Absorbance 
was measured at 562 nm. 0.5 M NaCl, 1 mM EDTA, 25 mM Tris–
HCl (pH 8) was used as blank. Also in this case, bovine serum 
albumin standards were used to construct a calibration curve. 
Protein concentrations were then calculated by comparing with a 
calibration curve of bovine serum albumin standards. 
 
 
Genome DNA detection 
 
For  amplification  of  the  16 s   rRNA   fragment,   specific   primers 




(Forward  primer:5'-cgttacccgcagaagaagca-3'  and  Reverse  
primer:5'-catctgacttaacaaaccgcctg-3') was used, PCR was 
performed with 30 cycles of denaturation at 94°C for 45 s, 
annealing at 54°C for 30 s and extension at 72°C for 30 s using a 
DNA thermal cycler [Applied Biosystems Inc. (ABI), CA, USA]. The 
fragments were recovered with gel recovery kit (Takara) and labeled 
with nucleic acid probe according to the direction of DIG DNA 
Labeling and Detection Kit (Roche).  
The gDNA of E. coli DH5 (75, 37.5, 18.7, 9.4 and 4.7 ng, 
respectively) was prepared with Genomic DNA Extraction Kit 
(OMEGA) and the purified plasmid DNA (0.5 and 1 g) were 
digested overnight with EcoR. Following digestion, the products 
were electrophoresised in a 1.0% Tris acetate-EDTA-agarose gel at 
80 V for 80 min and then the products were transferred to the 
positive charged nylon membrane by siphonage. After UV-
Crosslinking (330 nm/2 min), hybridization of nucleic acid was 
performed according to the direction of DIG DNA Labeling and 
Detection Kit. The condition of prehybridization (prehybridization 
solution containing 50% formylamine), hybridization (hybridization 
solution containing 50% formylamine) and ablution were 42°C for 4 




Endotoxin testing and safety assay   
 
Standard endotoxin sample and the purified plasmid DNA were 
diluted with free pyrogen deionized water into 0.2, 0.1, 0.05, 0.025, 
0.0125 and 0.006 EU/L and 1000, 500, 250, 125 and 62.5 ng/L 
respectively. Dilution was repeated twice each sample. Then 
tachypleus amebocyte lysate was added into 100 L aliquot of 
endotoxin standards or plasmid samples for 1 h incubation at 37°C. 
The results were judged according to the formation and fastness of 
the gels. The actual endotoxin content was calculated compared to 





COS-7, MDCK and Marc-145 cells were cultured in the DMEM 
supplemented with 10% fetal bovine serum close to confluence 
cells in 24-well microplate. The purified pcDNAlacZ by established 
technology and Kit as well as the conventional method were coated 
with polyetherimide (PEI, 25 kDa, Sigma), and then each 200 L 
PEI-DNA mixers were added into wells for incubation  at  37°C,  3 h 
later, the medium was replaced with complete medium supple-
mented with 10% calf serum. Forty eight hours later, the positive 
cells were detected by in situ -galactosidase staining kit (beyotime, 
China) and the transfection efficiency was calculated. 
Mice were randomly divided into 5 groups, 15 mice per group. 
The purified plasmid pcDNAlacZ were coated with PEI (25 kDa, 
Sigma). The first group was administrated with PBS as placebo, the 
second group, each mice was injected with pcDNA3.0 at a dose of 
20 g, while in group III, IV and V, each mice was immunized with 
20 g pcDNAlacZ purified by the established technology, Kit and 
conventional method. Three mice were killed every 4 days interval. 
Tissues of heart, liver, spleen, lung and kidney from the mice were 
collected and preserved in -20°C. The tissues were ground and 
then dissolved into 1×RLB solution. After centrifugation, the 
supernatant was collected.  
The concentration of protein was tested by bicinchonininc acid Kit 
which was obtained from Pierce (Rockford, IL, USA) and been 
adjusted to 5.0 g/mL with 1×RLB solution. Followed by this, the -
Galactosidase Enzyme activity in each tissue were detected 
according to the direction of -Galactosidase Enzyme Assay 
System With Reporter Lysis Buffer (Promega), and the average 













Selective precipitation of plasmid DNA 
 
After fermentation, the E. coli containing the pcDNAlacZ 
were collected for alkali lysis, and CTAB was titrated into 
the collected supernatant to a final concentration of 0 - 
0.25%. After incubation for 10 min at room temperature, 
the admixture was centrifugated at 6000 g, 15°C for 10 
min, the residual supernatant was detected for plasmid, 
host RNA and protein by spectrophotometry and gel 
electrophoresis. As shown in Figure 1, when the final 
CTAB concentration reached to 0.18%, all of the plasmid 
was precipitated. Meanwhile, total host RNA was still in 
the supernatant and approximately 28% of the host 
protein was co-precipitated with the plasmid. 
In order to validate whether the final CTAB concentra-
tion does work for different size and concentration of 
plasmid, 0.18% CTAB was added into the supernatant of 
each recombinant bacteria which contained the pCpG1, 
pCPG2, pCpG3, pCpG4, pMDT, pETA and pcDNK 
preserved in our laboratory. With the same operation, all 
the plasmids were total precipitated, while host RNA still 
retained in the supernatant, which indicated that the 
plasmid could be selectively precipitated effectively by 
CTAB at the final concentration of 0.18%. Furthermore, 
more than 90% of the precipitated plasmid DNA was 
presented as supercoiled form, and no contamination of 
RNA and host genome DNA were observed (Figure 2). 
 
 
Selective release of plasmid DNA 
 
The coprecipitated plasmids were dissolved with 10 mM 
TE (pH 8.0), PBS (pH 7.2), DDW, 3 M NaCl, 5 M NaCl, 1 
M NaAc, 3 M NaAc, 0.5 M NH4Ac, 1 M Na3PO4 and 3 M 
KAc, respectively. Then the solutions  were  centrifugated 






Figure 2. The electrophoresis of the different plasmid purified by CTAB. 
Lane 1 = pcDNAlacZ, 2 = pCpG1, 3 = pCPG2, 4 = pCpG3, 5 =  DNA 











and the supernatants were collected for quantification by 
spectrophotometry. We could see from Figure 3, the 
recovery rate of 3 M KAc is as high as 85%, while the 
other solvent recovery rate is relatively low. 
 
 
Digestion of the purified plasmids for identification 
 
The purified plasmid pcDNAlacZ was digested with 
HindIII and BamHI, HindIII and EcoRI, HindIII and XhoI, 
respectively. The results of agarose gel electrophoresis 
suggested that all pcDNAlacZ were correctly digested. 
Because of EcoRI site, pcDNAlacZ was digested into four 
fragments by HindIII and EcoRI but  two  by  other  diges- 
tions (Figure 4). Restriction digestion is an effective tool 
for quality verification of purified plasmid, with the aim of 
checking whether any unknown changes have taken 
place of the plasmids. In the present study, we choose 
pcDNAlacZ for the goal to verify that the plasmid 
precipitated by CTAB is feasible. The digestion results 
have proved that the CTAB will not have any impact on 
the precipitated plasmids. 
 
 
RNA detection of purified plasmids 
 
The supernatant with and without CTAB precipitation 
were collected for agarose gel electrophoresis, as can be 






Figure 4. The restriction map of CTAB-purified 
pcDNAlacZ. Lane 1 = enzyme digestion by HindIII 
and Apa I, 2 = enzyme digestion by HindIII and XhoI, 
3 = enzyme digestion by Hind III and EcoRI, 4 = 
enzyme digestion by Hind III and BamHI, and M = 






Figure 5. RNA detection by gel electrophoresis. Lane 
1 = The pcDNAlacZ precipitated with CTAB, 2 = the 
supernant after CTAB precipitation, 3 = the plasmid 
pcDNAlacZ without CTAB precipitation, and M = 





seen, after CTAB precipitation, all the bacterial RNA are 
all still retain in the supernatant, while almost all of the 
plasmid were precipitated, compared with the plasmid 
before precipitation, the bands shape, size and concen-
tration of the target plasmid did not change (Figure 5). 
 
 
Host protein detection of purified plasmids 
 
The plasmid pcDNAlacZ purified by CTAB and 3 M KAc 
was diluted by Sterile DDW at different concertrations for 
host protein quantification, and the results demonstrated 
that less than 1 ng host protein was detected in 1 µg 
plasmid, the residual host protein is very close to the 




Bacterial genome detection of purified plasmid 
 
The remnant bacterial genomic DNA in the purified 
plasmid was detected by Southern blotting with a digoxin 
labeled 16srRNA fragment as probe, as can be seen from 
Figure 6, the detection sensitivity of the probe for host 
gDNA is 10 ng, which just to satisfy the minimum require-
ment of purified plasmid, and less than 10 ng gDNA were 
detected in 1 µg purified plasmid, which meet the criterion 
stipulated by WHO (Robertson and Griffiths, 1998). 
 
 
Endotoxin detection  
 
The plasmid DNA was detected according to the direction 
of gel clot tachypleus amebocyte lysate, the results 
suggested that 1% TritonX-114 would remove the 
endotoxin efficiently at 42°C (Table 1). Meanwhile, the 
plasmid recovery rate was more than 98%, and only 50 
EU endotoxin was detected in 1 mg plasmid.  
 
 
Transfection in vitro 
 
The pcDNAlacZ were coated with PEI (25 kDa) and 
transfected into COS-7, MDCK and Marc-145 cell lines 
respectively. Forty eight hours later, the positive cells 
were counted for calculating the transfection efficiency, as 
can be shown from Figure 7, no significant differences of 
the transfection efficiency were found between the 
plasmid purified by the established technology (A, 35, 36 
and 15%) and endotoxin-free plasmid kit (B, 40, 38 and 
16%), but the efficiency were higher than the plasmid 
prepared by conventional method (C, 15, 16 and 8%). 
The results illustrate that the plasmid purified by the 
established technology has the same effect as the 
authoritative plasmid purification kit. 
 
 
Transfection in vivo 
 
Three mice were killed in each group on  2ndd,  4thd,  6thd, 






Figure 6. Detection of the host genomic DNA in the purified plasmid by 
Southern blotting. Lanes 1 – 5 = 75, 37.5, 19, 10 and 5 ng DH5 gDNA, 




Table 1. Endotoxin detection by limulus amoebocyte lysate. 
 
TritonX-114 (%) 1 2 3 
Temperature (°C) 20 26 32 42 20 26 32 42 20 26 32 42 
Endotoxin (EU/mg) 100 75 125 50 150 125 150 75 175 150 75 75 




































8thd and 10thd after they were injected with pcDNAlacZ. 
The tissues of heart, liver, spleen, lung and kidney were 
ground and dissolved into the schizolysis buffer of report 
gene. The concentration of protein was quantified and 
adjusted to 5.0 g/mL. The activity of -galactosidase 
enzyme in each tissue was detected, and the results 
showed that the enzyme activity was only detected in 
heart, spleen and lung tissues. The activities of A group 
was 54.54, 56.72 and 30.8 mU/mL, respectively. No signi-
ficant differences were observed between A and B. But 
the enzyme expression was higher compared to C 
(Figure 8). -galactosidase enzyme activity was detected 
on the different time after mice were injected with  recom- 
binant plasmid. The utmost expression was detected on 
the 4th day and the recombinant enzyme activity reduced 
significantly. Ten days later, enzyme activity could not be 
detected (data not shown). This result met the rule of 





With the rapid growth of genetic engineering technology, 
gene therapy and DNA vaccination become increasingly 
popular as novel ways of dealing with infectious diseases. 
However, the recombinant plasmids used for gene 
therapy and DNA vaccination require high quality and  the 



































Figure 8. -Galactosidase activity in different tissues of mice injected with pcDNALacZ 




process which contaminated with animal-derived 
enzymes, phenol and chloroform must be avoided. 
Therefore, large-scale plasmid purification becomes the 
bottleneck of gene therapy and DNA vaccination. 
The aim of the plasmid purification is to remove the 
bacterial RNA, endotoxin, host protein and genomic DNA, 
etc. In the present study, the RNA removal mainly depend 
on the tangential flow filtration (TFF) (Eon-Duval et al., 
2003) or salt such as MnCl2 and CaCl2 (Wahlund et al., 
2004; Shenoy et al., 2003), host genomic DNA removal 
by nitrocellulose has been described (Levy et al., 2000), 
and host protein been removed by hydrophobic 
interaction chromatography can be seen elsewhere 
(Diogo et al., 2000). Because of the similar charge and 
molecular weight with plasmid, the endotoxin is relative 
difficult to separate from the plasmid (Anspach, 2001). 
Now, methods such as chromatography had good 
prospects in plasmid purification, which is based on the 
negative charge and hydrophobicity of plasmids. The 
shortcomings are the high cost and tedious process. 
Although the idea of plasmid purification by TFF is very 
good, the plasmid mainly presented in negative super-
coiled form, and its actual molecular weight can not be 
reflected, so the purification result is not satisfying (Eon-
Duval et al., 2003). 
In this study, according to the interaction of CTAB with 
plasmid at low ion concentration, followed by alkali lysis 
CTAB was directly titrated into the supernatant. An easy 
and feasible technology for plasmid purification was 
established with the optimized proportion between the 
quantity of CTAB and  plasmid,  combined  with  3 M  KAc  
for DNA release and  TritonX-114  for  endotoxin  removal.  
The plasmids purified by this technology have charac-
teristics of high-purity, agarose gel electroelectrophoresis 
detection showed that the purified plasmid was free the 
contamination of host RNA (Figure 5). More than eighty 
percent of the prepared plasmids were presented in the 
supercoiled form (Figure 2), and the host protein, 
genomic DNA and endotoxin were less than 1, 10 g and 
50 EU in 1 mg plasmids (Figure 6, Table 1). Compared to 
the conventional large-scale plasmid purification, this 
technology for plasmid prepara-tion are free of animal-
derived enzymes, phenol, chloro-form, the expensive 
chromatographic column and filtra-tion membrane. 
Cell transfection assay is the conventional method to 
detect the quality of recombinant DNA. To verify the 
plasmid quality purified with this technology, the COS-7, 
MDCK and Marc-145 cell lines were transfected with 
pcDNAlacZ purified in this study and EndoFree Plasmid 
Mega Kit as well as conventional method, the results 
demonstrated that the transfection efficiency of the 
pcDNAlacZ purified by the established technology and Kit 
are almost similar, higher than the conventional method. 
Further in vivo experiment has showed that the 
pcDNAlacZ purified by established technology and kit 
obtained relative high level expression but by conven-
tional method (Figure 8).  
It is worth mentioning that this technology has the 
predominance of simple operation, low cost and safety, 
which can satisfy the demand of DNA vaccine, 
particularly the animal-used DNA vaccine for the 
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